Business Context and Reporting Period
This Form 8-K is a current report filed by MRI Interventions, Inc. (not Clearpoint Neuro, Inc.) on July 1, 2019, regarding an event that occurred on June 28, 2019. The registrant is incorporated in Delaware and its common stock (Symbol: MRIC) was previously traded on the OTCQB Marketplace.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a regulatory disclosure regarding a corporate event rather than a financial performance report.
Material Changes
- Exchange Listing Upgrade: The Company announced that its common stock has been approved for listing on the NYSE American.
- Trading Commencement: Trading on the NYSE American began at the open of trading on July 3, 2019.
- Symbol Retention: The stock will continue to trade under its current symbol, "MRIC."
Guidance, Outlook, and Risks
The filing contains no management guidance, financial outlook, or discussion of risks and contingencies. The document strictly serves to disclose the press release regarding the exchange listing under Item 7.01 (Regulation FD Disclosure). The press release is furnished as Exhibit 99.1 but is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the effective date of trading on the NYSE American (July 3, 2019).
- Confirm the continued use of the ticker symbol "MRIC" on the new exchange.
- Review the full text of the press release (Exhibit 99.1) for any additional details not summarized in the 8-K.
- Note that this filing does not contain updated financial statements or operational metrics.